Cargando…
CLINICAL TRIAL OF AN INDGENOUS COMPOUND DRUG NISHAAMALKI IN THE MANAGEMENT OF MADHUMEHA VIS-À-VIS DIABETES MELLITUS
A Clinical trial of Indigenous compound drug ‘Nishamalaki’ was carried out in the CRI (Ayurveda) Hospital, Jaipur on the patient of Madhumeha. For this study, patients were randomly divided into two groups of 25 individuals each and they were termed as group A and B. The individuals of group a were...
Autores principales: | Yadav, R.K., Mishra, R., Chhipa, R.P., Audichya, K.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3331030/ https://www.ncbi.nlm.nih.gov/pubmed/22557029 |
Ejemplares similares
-
CONSTITUTIONAL STUDY OF PATIENTS OF DIABETES MELLITUS VIS-À-VIS MADHUMEHA
por: Bharti,, et al.
Publicado: (1995) -
Vis Conservatrix
por: Payne, F. R.
Publicado: (1867) -
PHARMACEUTICAL PROCESSING IN PANCHAKARMA VIS –A-VIS POLIO MYELITIS
por: Chaube, Anjana, et al.
Publicado: (1996) -
Citicoline and COVID-19: vis-à-vis conjectured
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
The Pathogenesis of Adenomyosis vis-à-vis Endometriosis
por: Guo, Sun-Wei
Publicado: (2020)